Does adherence to medications for type 2 diabetes differ between individuals with VS without schizophrenia?

Schizophrenia Bulletin

Volumn 36, Issue 2, 2010, Pages 428-435

  Kreyenbuhl, Julie ^a,b   Dixon, Lisa B ^a,b   McCarthy, John F ^c,d   Soliman, Soheil ^e   Ignacio, Rosalinda V ^c,d   Valenstein, Marcia ^c,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Education   (United States)

^c VA Serious Mental Illness Treatment Research and Evaluation Center   (United States)

^d Department of Psychiatry ^*  (Australia)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Administrative data; Co occurring medical conditions

Indexed keywords

NEUROLEPTIC AGENT; ORAL ANTIDIABETIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HOMELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADMINISTRATION, ORAL; ADULT; COMORBIDITY; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHOTIC DISORDERS; REFERENCE VALUES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VETERANS;

EID: 77749279563     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn106     Document Type: Article

References (40)

1. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics fact sheet: general information and national estimates on diabetes in the United States 2005. Bethesda, MD: U. S. Department of Health and Human Services, National Institute of Health 2005.
2. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidi-abetic medication adherence and glycemic control in managed care. Am J Manag Care. 2008;14:71-75.
3. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166: 1836-1841.
4. Lawrence DB, Ragucci RK, Long LB, et al. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm. 2006;12(6):466-471.
5. Krapek K, King K, Warren SS, Parris BS, Helfer LA. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004;38:1357-1362.
6. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27:2800-2805.
7. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015-1021.
8. Lau DT, Nau DP. Oral antihyperglycemic medication nonad-herence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27:2149-2153.
9. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
10. Hepke KL, Martus MT, Share DA. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care. 2004;10:144-151.
11. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25:2958-2971.
12. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-1224.
13. Sokal J, Messias E, Dickerson FB, et al. Co-morbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192(6):421-427.
14. Citrome L, Jaffe A, Levine J, Martello D. Incidence, prevalence, and surveillance for diabetes in New York State psychiatric hospitals, 1997-2004. Psychiatr Serv. 2006;57(8):1132-1139.
15. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):1-14. [serial online] [Accessed: October 30, 2007]. Available from: URL: http://www. cdc. gov/pcd/ issues/2006/apr/05-0180. htm.
16. McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study. Br J Psychiatry. 2003;183(6):534-539.
17. Gilmer TP, Dolder CR, Lacro JP, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161:692-699.
18. Valenstein M, Blow FC, Copeland LA, et al. Poor antipsy-chotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull. 2004;30(2):255-264.
19. Valenstein M, Copeland LA, Blow FC, et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care. 2002;40:630-639.
20. Dolder CR, Lacro JP, Jeste DV. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Psychosom Med. 2003;65(1):156-162.
21. Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension. Psy-chiatr Serv. 2007;58:207-212.
22. Dolder CR, Furtek K, Lacro JP, Jeste DV. Antihypertensive medication adherence and blood pressure control in patients with psychotic disorders compared to persons without psychiatric illness. Psychosomatics. 2005;46(2):135-141.
23. Blow FC, McCarthy JF, Valenstein M, Zeber JF, Gillon L. Care in the VHA for Veterans with Psychosis: FY04. Sixth Annual Report on Veterans with Psychoses. Serious Mental Illness Treatment Research and Evaluation Center, Ann Arbor, Michigan, July 2005.
24. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(suppl 2):B10-B21.
25. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
26. McCarthy JF, Valenstein M, Blow FC. Residential mobility among patients in the VA health system: associations with psychiatric morbidity, geographic accessibility, and continuity of care. Adm Policy Ment Health. 2007;34(5):448-455.
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
28. Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005;165:2631-2638.
29. Whyte S, Penny C, Phelan M, Hippisley-Cox J, Majeed A. Qual-ity of diabetes care in patients with schizophrenia and bipolar disorder: cross-sectional study. Diabet Med. 2007;24:1442-1448. (Pubitemid 350179455)
30. Goldberg RW, Kreyenbuhl J, Dickerson FB, et al. Quality of diabetes care among adults with serious mental illness. Psy-chiatr Serv. 2007;58(4):536-543.
31. Krein SL, Bingham CR, McCarthy JF, Mitchinson A, Payes J, Valenstein M. Diabetes treatment among VA patients with comorbid serious mental illness. Psychiatr Serv. 2006;57(7):1016-1021.
32. Weiss AP, Henderson DC, Weilburg JB, et al. Treatment of cardiac risk factors among patients with schizophrenia and diabetes. Psychiatr Serv. 2006;57(8):1145-1152.
33. Dixon LB, Kreyenbuhl JA, Dickerson FB, et al. A comparison of type 2 diabetes outcomes among persons with and without severe mental illness. Psychiatr Serv. 2004;55:892-900.
34. Desai MM, Rosenheck RA, Druss BG, Perlin JB. Mental disorders and quality of diabetes care in the veterans health administration. Am J Psychiatry. 2002;159:1584-1590.
35. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(suppl 1):1-93.
36. Dixon LB, Adler DA, Berlant JL, et al. Psychiatrists and primary caring: what are our boundaries of responsibility? Psychiatr Serv. 2007;58(5):600-602.
37. Rogers WH, Kazis LE, Miller DR, et al. Comparing the health status of VA and non-VA ambulatory patients: the veterans' health and medical outcomes studies. J Ambul Care Manage. 2004;27:249-262.
38. Shen YA, Hendricks A, Zhang S, Kazis LE. VHA enrollees' health care coverage and use of care. Med Care Res Rev. 2003;60(2):253-267.
39. Dickinson D, Gold JM, Dickerson FB, Medoff D, Dixon LB. Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes. Psychosomatics. 2008;49(2):123-131.
40. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for eval- uationofmedication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565-574.